LDN: Innovations in Autoimmune Treatment - Dr Leonard Weinstock, MD

From The LDN Radio Show About Low Dose Naltrexone by Linda Elsegood

June 10, 2026 · 20 min · Season 33 · Episode 10

About this episode

This episode discusses innovative microdosing protocols for Low Dose Naltrexone and its applications in treating autoimmune diseases.

This professional discussion explores the innovative microdosing protocol for Low Dose Naltrexone (LDN) developed by Dr. Norman Marcus. The conversation highlights its effectiveness in managing autoimmune diseases, cancers, and particularly Mast Cell Activation Syndrome (MCAS). Learn about the challenges and advancements in LDN therapy and its growing applications.

People in this episode

Host: Linda Elsegood

Guest: Dr Leonard Weinstock

Topics covered

Low Dose Naltrexone
autoimmune diseases
microdosing protocol
Mast Cell Activation Syndrome
cancer treatment
LDN therapy advancements

Keywords

Low Dose Naltrexone
autoimmune treatment
microdosing
Mast Cell Activation Syndrome
cancer
LDN therapy

More episodes of The LDN Radio Show About Low Dose Naltrexone

LDN for Neuropathy and Pain by Deborah · June 10, 2026 · 29 min

Explore listener stats, chart rankings, contacts and more on the The LDN Radio Show About Low Dose Naltrexone podcast page.